EMG
HZNP

Ellington Management Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Ellington Management Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,700
Closed -$319K – 848
2019
Q3 		$319K Buy
+11,700
New +$303K 0.07% 349
2019
Q2 		– Sell
-12,800
Closed -$338K – 893
2019
Q1 		$338K Buy
+12,800
New +$303K 0.07% 326
2014
Q3 		– Sell
-12,600
Closed -$199K – 534
2014
Q2 		$199K Buy
+12,600
New +$180K 0.09% 364
2014
Q1 		– Sell
-48,800
Closed -$372K – 834
2013
Q4 		$372K Buy
+48,800
New +$263K 0.13% 253

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return